These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2298029)
1. Cellular immunotherapy of cancer. Topalian SL; Rosenberg SA Crit Care Med; 1990 Feb; 18(2 Suppl):S144. PubMed ID: 2298029 [No Abstract] [Full Text] [Related]
2. Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC). Oldham RK; Lewko WM; Good RW; Sharp E In Vivo; 1994; 8(5):653-63. PubMed ID: 7537108 [TBL] [Abstract][Full Text] [Related]
3. Clinical use of interleukin-2 in treating cancer. Patterson DL; Wiemann MC Indiana Med; 1991 Aug; 84(8):534-7. PubMed ID: 1918915 [No Abstract] [Full Text] [Related]
4. [Care of advanced tumor treated by interleukin-2 and lymphokine-activated killer cells]. Wu Y; Li LC Zhonghua Hu Li Za Zhi; 1994 Nov; 29(11):654-6. PubMed ID: 7614584 [No Abstract] [Full Text] [Related]
5. [Cancer immunotherapy: immunologic bases, reality and hopes]. Dietrich PY; Farace F; Caignard A; Escudier B; Triebel F Bull Cancer; 1993 Jul; 80(7):584-600. PubMed ID: 8204939 [TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy of malignant diseases using interleukin 2. Bases, results, trends]. Gause A; Pfreundschuh M Med Klin (Munich); 1990 Sep; 85(9):561-6, 570. PubMed ID: 2233615 [No Abstract] [Full Text] [Related]
8. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation. Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186 [TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells]. Osanto S; Brand A; van Rood JJ; Cleton FJ Ned Tijdschr Geneeskd; 1989 Jul; 133(28):1392-5. PubMed ID: 2677758 [No Abstract] [Full Text] [Related]
10. [Autologous tumor specific immunotherapy of refractory cancers with ex vivo-generated T cells stimulated by autologous tumor cell]. Toh U; Yamana H; Kido K; Mine T; Fujii T; Horiuchi H; Sasatomi T; Ishibashi N; Yutani S; Fujita H; Shirouzu K Gan To Kagaku Ryoho; 2003 Oct; 30(11):1566-70. PubMed ID: 14619465 [TBL] [Abstract][Full Text] [Related]
11. [Our experience with lymphocytes activated against cancer: CTL cells]. Marcellino LR; Vinciguerra M; Marcellino MV; Sessa E G Chir; 1997 Oct; 18(10):605-7. PubMed ID: 9479972 [TBL] [Abstract][Full Text] [Related]
12. [Adoptive immunotherapy with interleukin-2 and with interleukin-2 activated lymphocytes]. Eggermont AM; Stoter G; Jansen RL; Bolhuis RL Ned Tijdschr Geneeskd; 1989 Jul; 133(28):1387-92. PubMed ID: 2677757 [No Abstract] [Full Text] [Related]
13. [Quality control of biological therapy in patients with tumors]. Zhang S Zhonghua Yi Xue Za Zhi; 1996 Jul; 76(7):483-4. PubMed ID: 9275493 [No Abstract] [Full Text] [Related]
14. Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2. Sacchi M; Snyderman CH; Heo DS; Johnson JT; d'Amico F; Herberman RB; Whiteside TL Cancer Res; 1990 May; 50(10):3113-8. PubMed ID: 2334906 [TBL] [Abstract][Full Text] [Related]
15. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Burns LJ; Weisdorf DJ; DeFor TE; Vesole DH; Repka TL; Blazar BR; Burger SR; Panoskaltsis-Mortari A; Keever-Taylor CA; Zhang MJ; Miller JS Bone Marrow Transplant; 2003 Jul; 32(2):177-86. PubMed ID: 12838283 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 in autologous bone marrow transplantation. Charak BS Natl Med J India; 1993; 6(1):19-22. PubMed ID: 8453356 [TBL] [Abstract][Full Text] [Related]
17. [Adoptive immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes]. van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH Ned Tijdschr Geneeskd; 1989 Oct; 133(40):1994-5. PubMed ID: 2812087 [No Abstract] [Full Text] [Related]
19. Lymphokine-activated killer lymphocytes: National Cancer Institute clinical trials. Clark J; Longo DL Immunol Ser; 1989; 48():37-58. PubMed ID: 2488325 [No Abstract] [Full Text] [Related]
20. Lymphokine activated killer cells: a new approach to immunotherapy of cancer. Semenzato G Leukemia; 1990 Feb; 4(2):71-80. PubMed ID: 2406518 [No Abstract] [Full Text] [Related] [Next] [New Search]